Gunung Raja Paksi Tbk. vs Merck Tbk. — how do they compare? Gunung Raja Paksi Tbk. trades at Rp294 (market cap 3.58T, 523.1K 24h volume), while Merck Tbk. trades at Rp3,850 (market cap 1.7T, 24.6K 24h volume). The key difference: Gunung Raja Paksi Tbk. is far larger — about 2.1× Merck Tbk.'s market cap, and Gunung Raja Paksi Tbk. is more actively traded (523.1K versus 24.6K). Which is the better fit depends on your goals.
| GGRP | MERK | |
|---|---|---|
Market Cap | 3.58T | 1.7T |
Volume | 523.1K | 24.6K |
Lot | 5.23K | 246 |
Turnover | 153.32M | 94.38M |
Average Price | 293.1 | 3,836.59 |
Value | 153.32M | 94.38M |
Indicative Equilibrium Price | 296 | 3,850 |
Indicative Equilibrium Volume | 300 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Gunung Raja Paksi Tbk (the Company) was established under the name of PT Gunung Naga Mas based on Notarial Deed No.229 of Chairani Bustami,S.H. dated August 20,1990 that was amended by Notarial Deed No.25 dated June 6,1991. The change from Foreign Capital Investment (“FCI”) to Domestic Capital Investment (“DCI”) has been approved by the Capital Investment Coordinating Board of the Republic of Indonesia in its Letter No.346/1/IP/PMDN/2016 dated December 15, 2016.
Read more on GGRP →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →